Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students

Pharmacotherapy

Volumn 33, Issue 1, 2013, Pages 44-50

  Dietz, Pavel ^a   Striegel, Heiko ^b   Franke, Andreas G ^c   Lieb, Klaus ^c   Simon, Perikles ^a   Ulrich, Rolf ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Academics; Brain doping; Drug abuse; Epidemiology; Pharmacology

Indexed keywords

NOOTROPIC AGENT;

ADOLESCENT; ADULT; ARTICLE; DOPING; FEMALE; GERMANY; HUMAN; MALE; PREVALENCE; QUESTIONNAIRE; SEX DIFFERENCE; UNIVERSITY STUDENT;

ADOLESCENT; ADULT; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; NOOTROPIC AGENTS; PREVALENCE; QUESTIONNAIRES; STUDENTS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; UNIVERSITIES; YOUNG ADULT;

EID: 84875441999     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/phar.1166     Document Type: Article

References (43)

1. Maher B. Poll results: look who's doping. Nature 2008;452:674-5.
2. Hall KM, Irwin MM, Bowman KA, Frankenberger W, Jewett DC. Illicit use of prescribed stimulant medication among college students. J Am Coll Health 2005;53:167-74.
3. Kaloyanides KB, McCabe SE, Cranford JA, Teter CJ. Prevalence of illicit use and abuse of prescription stimulants, alcohol, and other drugs among college students: relationship with age at initiation of prescription stimulants. Pharmacotherapy 2007;27:666-74.
4. McCabe SE, Teter CJ, Boyd CJ. Medical use, illicit use and diversion of prescription stimulant medication. J Psychoactive Drugs 2006;38:43-56.
5. Wilens TE, Adler LA, Adams J, et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry 2008;47:21-31.
6. McCabe SE, Knight JR, Teter CJ, Wechsler H. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 2005;100:96-106.
7. Babcock Q, Byrne T. Student perceptions of methylphenidate abuse at a public liberal arts college. J Am Coll Health 2000;49:143-5.
8. Teter CJ, McCabe SE, Boyd CJ, Guthrie SK. Illicit methylphenidate use in an undergraduate student sample: prevalence and risk factors. Pharmacotherapy 2003;23:609-17.
9. Deutsche Angestellten Krankenkasse. DAK Gesundheitsreport 2009: analysen der Arbeitsunf€ahigkeitsdaten, Schwerpunktthema Doping am Arbeitsplatz. Available from http://www.dak.de/content/filesopen/Gesundheitsreport-2009.pdf. Accessed March 29, 2012.
10. Teter CJ, McCabe SE, LaGrange K, Cranford JA, Boyd CJ. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 2006;26:1501-10.
11. Franke AG, Bonertz C, Christmann M, et al. Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry 2011;44:60-6.
12. Franke AG, Christmann M, Bonertz C, Fellgiebel A, Huss M, Lieb K. Use of coffee, caffeinated drinks and caffeine tablets for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry 2011;44:331-8.
13. Musch J, Bröoder A, Klauer KC. Improving survey research on the world-wide web using the randomized response technique. In: Reips U, Bosnjak M, eds. Dimensions of internet science. Lengerich, Germany: Pabst Science Publishers, 2001:179-92.
14. Greenberg BG, Abulela ALA, Simmons WR, Horvitz DG. Unrelated question randomized response model-theoretical framework. J Am Stat Assoc 1969;64:520-36.
15. Nordlund S, Holme I, Tamsfoss S. Randomized response estimates for the purchase of smuggled liquor in Norway. Addiction 1994;89:401-5.
16. Simon P, Striegel H, Aust F, Dietz K, Ulrich R. Doping in fitness sports: estimated number of unreported cases and individual probability of doping. Addiction 2006;101:1640-4.
17. Striegel H, Ulrich R, Simon P. Randomized response estimates for doping and illicit drug use in elite athletes. Drug Alcohol Depend 2010;106:230-2.
18. Moshagen M, Musch J, Ostapczuk M, Zhao Z. Reducing socially desirable responses in epidemiologic surveys: an extension of the randomized-response technique. Epidemiology 2010;21:379-82.
19. Arvary D, Pope HG Jr. Anabolic-androgenic steroids as a gateway to opioid dependence. N Engl J Med 2000;342:1532.
20. Ulrich R, Schröuro;oter H, Striegel H, Simon P. Asking sensitive questions: a statistical power analysis of randomized response models. [published online ahead of print August 27, 2012. Psychol Meth. DOI: 10.1037/a0029314.
21. Lensvelt-Mulders G, Hox JJ, van der Heuden PGM, Maas CJM. Meta-analysis of randomized response research thirtyfive years of validation. Soc Method Res 2005;33:319-48.
22. DeSantis AD, Webb EM, Noar SM. Illicit use of prescription ADHD medications on a college campus: a multimethodological approach. J Am Coll Health 2008;57:315-24.
23. Repantis D, Laisney O, Heuser I. Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review. Pharmacol Res 2010;61:473-81.
24. Repantis D, Schlattmann P, Laisney O, Heuser I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacol Res 2010;62:187-206.
25. Ellinwood EH Jr. Assault and homicide associated with amphetamine abuse. Am J Psychiatry 1971;127:1170-5.
26. Franke AG, Lieb K. Pharmacological neuroenhancement and brain doping: chances and risks. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2010;53:853-9.
27. McCormick RA, Smith M. Aggression and hostility in substance abusers: the relationship to abuse patterns, coping style, and relapse triggers. Addict Behav 1995;20:555-62.
28. Morton WA, Stockton GG. Methylphenidate abuse and psychiatric side effects. Prim Care Companion J Clin Psychiatry 2000;2:159-64.
29. Bymes JP, Miller DC, Schafer WD. Gender differences in risk taking: a meta-analysis. Psychol Bull 1999;125:367-83.
30. Grunberg NE, Winders SE, Wewers ME. Gender differences in tobacco use. Health Psychol 1991;10:143-53.
31. Bundesministerium fur Gesundheit (Federal Ministry of Health). Drogen- und Suchtbericht 2011. Available from http://www.drogenbeauftragte.de/fileadmin/ dateien-dba/Service/Publikationen/Drogen-und-Suchtbericht-2011-110517- Drogenbeauftragte.pdf. Accessed April 17, 2011.
32. Vigna-Taglianti F, Vadrucci S, Faggiano F, et al. Is universal prevention against youths' substance misuse really universal? Gender-specific effects in the EU-Dap school-based prevention trial J Epidemiol Community Health 2009;63:722-8.
33. Akmatov MK, Mikolajczyk RT, Meier S, Kramer A. Alcohol consumption among university students in North Rhine-Westphalia, Germany results from a multicenter cross-sectional study. J Am Coll Health 2011;59:620-6.
34. Anthony JC, Echeagaray-Wagner F. Epidemiologic analysis of alcohol and tobacco use. Alcohol Res Health 2000;24:201-8.
35. Wanjek B, Rosendahl J, Strauss B, Gabriel HH. Doping, drugs and drug abuse among adolescents in the State of Thuringia (Germany): prevalence, knowledge and attitudes. Int J Sports Med 2007;28:346-53.
36. Sundgot-Borgen J, Berglund B, Torstveit MK. Nutritional supplements in Norwegian elite athletes-impact of international ranking and advisors. Scand J Med Sci Sports 2003;13:138-44.
37. Ayotte C, Levesque JF, Cle roux M, Lajeunesse A, Goudreault D, Fakirian A. Sport nutritional supplements: quality and doping controls. Can J Appl Physiol 2001;26:120-9.
38. Baylis A, Cameron-Smith D, Burke LM. Inadvertent doping through supplement use by athletes: assessment and management of the risk in Australia. Int J Sport Nutr Exerc Metab 2001;11:365-83.
39. Kanayama G, Gruber AJ, Pope HG Jr, Borowiecki JJ, Hudson JI. Over-the-counter drug use in gymnasiums: an underrecognized substance abuse problem? Psychother Psychosom 2001;70:137-40.
40. Striegel H, Simon P, Wurster C, Niess AM, Ulrich R. The use of nutritional supplements among master athletes. Int J Sports Med 2006;27:236-41.
41. Striegel H, Simon P, Frisch S, et al. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system. Drug Alcohol Depend 2006;81:11-9.
42. DuRant RH, Rickert VI, Ashworth CS, Newman C, Slavens G. Use of multiple drugs among adolescents who use anabolic steroids. N Engl J Med 1993;328:922-6.
43. Yesalis CE, Kennedy NJ, Kopstein AN, Bahrke MS. Anabolicandrogenic steroid use in the United States. JAMA 1993;270:1217-21.